−£53k
vs Nov 2023Active09852621Private limited companyWitney
ESTRYX PHARMA LIMITED
Significant control: Oxandia Limited (25–50%), Professor Barry Victor Lloyd Potter (25–50%)
From public filings as at 31 Aug 2026; may contain errors or be out of date. Verify at Companies House · Terms
Watch this company
Get an email when Companies House records a change for Estryx Pharma Limited: status, filings, accounts, officers or owners. Free.
Not live yet: alerts start by 15 December 2026. We store your email and this company number only, for these alerts. If alerts don’t launch, we tell you and delete your address. Privacy
Coming soon · product and service lists
What does Estryx Pharma Limited sell?
Registered activity: Research and experimental development on biotechnology (SIC 72110). We’re building product and service lists for UK companies. Get this one when it’s ready.
One email, only about this. If we don’t launch within 60 days we’ll tell you. Privacy
01
Summary
ESTRYX PHARMA LIMITED is an active private limited company (company number 09852621) incorporated on 2 November 2015, registered in Witney. Its registered activity is research and experimental development on biotechnology (SIC 72110). Latest micro accounts cover the period ending 30 November 2024, showing net assets of −£53k, with 2 employees on average. As micro-entity accounts, no profit and loss account is filed, so turnover and profit are not public. Net assets fell 59% on the prior period (−£34k).
Peer position · net assets
By net assets it sits in the bottom quarter of 152 comparable companies in Oxford (median £10k, upper quartile £474k).
02
Ownership and control
- Oxandia Limited
- owns 25–50% of shares
- holds 25–50% of voting rights
- can appoint or remove directors
- Professor Barry Victor Lloyd Potter
- owns 25–50% of shares
- holds 25–50% of voting rights
Persons with significant control hold 25% or more of shares or voting rights. Smaller shareholdings are only listed in confirmation-statement documents. Directors and secretaries: see the officers list at Companies House.
03
Key dates
- Incorporated
- 2 November 201510 yrs ago
- Next accounts due
- 30 August 202657 days overdue
- Confirmation statement due
- 16 November 2026in 21 days
Due dates are expected from Companies House filing rules; confirm on the official register before relying on them.
04
Activity
- SIC 72110
- Research and experimental development on biotechnology
- Accounts type
- Micro Entity
- Size band
- MicroCompanies Act thresholds
05
Financials
Not reported
Not disclosed
2
No changevs Nov 2023| Period end | Net assets | Cash | Debtors | Creditors <1y | Turnover | Profit | Employees |
|---|---|---|---|---|---|---|---|
| 30 November 2024 | −£53k | — | — | £76k | — | — | 2 |
| 30 November 2023 | −£34k | — | — | £71k | — | — | 2 |
Current ratio0Current assets ÷ creditors within one year
Figures as filed in iXBRL accounts at Companies House. "—" means the line was not reported in that filing; micro-entity accounts contain no profit and loss account.
06
Filing and accounts signals
- Net assets below zeroNet assets £-53,488 at 30 November 2024
- Net assets down 25% or more on the prior period-59.4% vs prior period
- Current assets below creditors within one yearCurrent ratio 0.0
- Incorporated five or more years agoIncorporated 2 November 2015
- Accounts past their due dateDue 30 August 2026
Neutral facts read from the register and filed accounts, each with its evidence. They are not a rating, a prediction or advice, and may be incomplete or out of date. How each signal is derived.
07
Timeline
- Confirmation statement duein 21 days
- Next accounts due57 days overdue
- Accounts period endNet liabilities £53k · micro accounts
- Accounts period endNet liabilities £34k · micro accounts
- Incorporated
08
Similar companies in Oxford
- OPTELLUM LTDOxford · inc. Oct 2015
- T-CYPHER BIO LIMITEDAbingdon · inc. Oct 2015
- OXFORD ENDOVASCULAR LIMITEDOxford · inc. Sept 2015
- THE GENOME FOUNDRY LIMITEDOxford · inc. Sept 2015
- TAILORED CLINICAL RESEARCH SOLUTIONS LIMITEDOxford · inc. Dec 2015
- GYLDEN PHARMA LIMITEDAbingdon · inc. Jan 2016
All companies incorporated on 2 November 2015 · in Nov 2015.
09
Reminders for ESTRYX PHARMA LIMITED
Get an email before each filing deadline — accounts and confirmation statement — so nothing is late.